Efficacy of liposomal bupivacaine in spine surgery: a systematic review

医学 随机对照试验 脊柱(分子生物学) 麻醉 布比卡因 类阿片 外科 鞘内 前瞻性队列研究 背痛 梅德林 术后疼痛
作者
Tommy Nguyen,Cesar Iturriaga,Rohit Verma
出处
期刊:The Spine Journal [Elsevier]
卷期号:21 (9): 1450-1459 被引量:26
标识
DOI:10.1016/j.spinee.2021.02.014
摘要

Spine surgery with posterior approaches may involve extensive manipulation of native structures, resulting in significant postoperative pain. Liposomal bupivacaine (LB) is an injectable analgesic that has demonstrated efficacy in decreasing postoperative pain and opioid requirements in patients across multiple surgical subspecialties.To consolidate and analyze the findings of retrospective cohort-matched studies and prospective randomized controlled trials investigating the use of LB in spine surgery.A systematic review.Retrospective cohort-matched studies and randomized controlled trials (RCTs) investigating the efficacy of injected LB in spinal surgery compared with a control/no treatment group.MEDLINE, Cochrane controlled trials register, and Google Scholar were searched to identify all studies that examined the effect of LB use on outcomes in spine surgery. Our search identified 10 articles that independently evaluated the effect of LB on reduction of postoperative opioid use, pain scores, hospital length of stay, cost, and incidence of adverse effects. The principles of GRADE (Grading of Recommendations, Assessment, Development, and Evaluations) were applied to assess the quality of evidence from each study.Ten studies were analyzed (1,112 total patients). LB was associated with significantly lower millimolar morphine equivalents (MME) of postoperative opioids, especially in opiate-tolerant patients, visual analog scale (VAS) scores, area under the curve (AUC) of cumulative pain scores, numeric pain scale scores, and hospital length of stay (LOS), with comparable or lower odds of adverse effects relative to controls.Low-quality evidence suggests that liposomal bupivacaine may safely decrease postoperative opioid requirements, pain scores, and length of stay in patients undergoing spine surgery, whereas moderate-quality evidence does not support its use at this time. Therefore, additional standardized well-powered prospective studies are necessary to more clearly assess the efficacy of LB in spine surgery.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Yashyi发布了新的文献求助10
刚刚
Libra完成签到,获得积分10
刚刚
昆明官渡酒店完成签到,获得积分10
刚刚
wuge5857发布了新的文献求助30
1秒前
Sch完成签到,获得积分10
1秒前
小蘑菇应助NONO采纳,获得10
1秒前
2秒前
2秒前
DZT关闭了DZT文献求助
2秒前
一锅粥完成签到,获得积分10
2秒前
star应助超帅的开山采纳,获得10
2秒前
深情安青应助超帅的开山采纳,获得10
2秒前
2秒前
邱化兴发布了新的文献求助10
2秒前
3秒前
卫三发布了新的文献求助10
3秒前
那时的苹果完成签到,获得积分10
4秒前
4秒前
无花果应助Sereno采纳,获得10
4秒前
李彬发布了新的文献求助10
5秒前
LYSM应助任磊采纳,获得10
5秒前
传奇3应助mani采纳,获得20
5秒前
翊然甜周发布了新的文献求助10
5秒前
xxzw完成签到 ,获得积分10
6秒前
魔幻毛豆发布了新的文献求助10
6秒前
musicyy222发布了新的文献求助10
6秒前
酷酷忆安发布了新的文献求助10
7秒前
Avvei完成签到,获得积分10
7秒前
量子星尘发布了新的文献求助10
7秒前
8秒前
noriZHC发布了新的文献求助10
8秒前
小欣发布了新的文献求助10
8秒前
9秒前
9秒前
小雪给小雪的求助进行了留言
9秒前
xxzw关注了科研通微信公众号
9秒前
Sun1c7发布了新的文献求助10
10秒前
hu123发布了新的文献求助10
10秒前
dunhuang完成签到,获得积分10
10秒前
Lucas应助小付采纳,获得10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
List of 1,091 Public Pension Profiles by Region 1581
Encyclopedia of Agriculture and Food Systems Third Edition 1500
以液相層析串聯質譜法分析糖漿產品中活性雙羰基化合物 / 吳瑋元[撰] = Analysis of reactive dicarbonyl species in syrup products by LC-MS/MS / Wei-Yuan Wu 1000
Lloyd's Register of Shipping's Approach to the Control of Incidents of Brittle Fracture in Ship Structures 800
Biology of the Reptilia. Volume 21. Morphology I. The Skull and Appendicular Locomotor Apparatus of Lepidosauria 600
The Limits of Participatory Action Research: When Does Participatory “Action” Alliance Become Problematic, and How Can You Tell? 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 物理化学 基因 遗传学 催化作用 冶金 量子力学 光电子学
热门帖子
关注 科研通微信公众号,转发送积分 5545599
求助须知:如何正确求助?哪些是违规求助? 4631588
关于积分的说明 14621327
捐赠科研通 4573203
什么是DOI,文献DOI怎么找? 2507433
邀请新用户注册赠送积分活动 1484163
关于科研通互助平台的介绍 1455416